In this Genetic Engineering & Biotechnology News article, “Downstream Trends and Challenges,” the author discusses the increasing complexity and challenges facing manufacturers today. ScaleReady is mentioned as a joint venture designed to better serve cell therapy developers with scaleable, flexible platforms from established partners.
In this Genetic Engineering & Biotechnology News article, “Downstream Trends and Challenges,” the author discusses the increasing complexity and challenges facing manufacturers today. ScaleReady is mentioned as a joint venture designed to better serve cell therapy developers with scaleable, flexible platforms from established partners.